Order Center

Use the Order Center to build a Shopping Cart, view Saved Shopping Carts, Recent Orders and Quotes

MSDS

Search for MSDS (Material Safety Data Sheet) by Product Number

Oligo Ordering

Custom Products and Services, including DNA oligos (Primers and Probes), RNA, siRNA, Peptide Libraries and AQUA Peptides

Corporate

Sigma-Aldrich is a leading Life Science and High Technology Materials company focused on enabling science to improve the quality of life

Contact Us

Contact Customer Service

Web Toolbox

The Sigma-Aldrich Web Toolbox features helpful online science research tools and resources

Save 50% on Halogenated Heterocyles

Find the Halogenated Heterocycle that matches your needs from our extensive selection of structures.

Brands & Grades

By knowing how our portfolio is organised, you can easily find a product suitable for your application

Newsletters

Subscribe to free eNews and other newsletters from Sigma-Aldrich

News & Information

South Africa - March 21, 2012 Please note that the import of animal origin products into South Africa are currently being regulated

New Report Shows Positive Impacts of Company's Global Citizenship Efforts

This means that there could be products that you require, that we are presently unable to import e.g. animal serums, albumins, gelatins, milk powders. Please contact the office if you are unsure on whether your product can be supplied.

Read More
St. Louis, MO - June 30, 2014 Sigma-Aldrich CFO Jan Bertsch Named One of St. Louis’ Most Influential Business Women

Sigma-Aldrich Corporation (NASDAQ: SIAL) is proud to announce that Executive Vice President and Chief Financial Officer Jan Bertsch has been named one of St. Louis’ Most Influential Business Women by the St. Louis Business Journal.

Read More
St. Louis, MO - June 24, 2014 AGTC and SAFC Create Strategic Partnership to Provide Gene Therapy Manufacturing Services

Applied Genetic Technologies Corporation (NASDAQ: AGTC), a clinical stage biotechnology company developing adeno-associated virus (AAV)-based gene therapies for the treatment of rare eye diseases, and SAFC Commercial (SAFC), the Sigma-Aldrich Corporation (NASDAQ: SIAL) business unit that manufactures specialty chemicals and biologics for commercial life science applications, today announced that they signed an agreement to have SAFC provide gene therapy manufacturing services to companies developing gene-based therapies.

Read More
St. Louis, MO - May 20, 2014 SAFC Expands Continuous Flow Capabilities for Research and Commercial Scale

Sigma-Aldrich Corporation (NASDAQ: SIAL) today announced that SAFC® Commercial, its custom manufacturing services business unit, has installed a new commercial-scale continuous flow reactor at its Sheboygan, Wis., facility with  capacity to produce up to 150 kg of product per day.

Read More